Black Rock Inc. Alkermes Plc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Black Rock Inc. holds 29,107,548 shares of ALKS stock, worth $805 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
29,107,548
Previous 29,168,481
0.21%
Holding current value
$805 Million
Previous $790 Million
11.16%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding ALKS
# of Institutions
386Shares Held
166MCall Options Held
231KPut Options Held
158K-
Vanguard Group Inc Valley Forge, PA18.5MShares$512 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$339 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$244 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$209 Million3.55% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny5.48MShares$152 Million0.25% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.54B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...